DNLI icon

Denali Therapeutics
DNLI

Overview Fund Trends Analyst Outlook Journalist POV

45 hedge funds and large institutions have $909M invested in Denali Therapeutics in 2017 Q4 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$322M
2
+$146M
3
+$139M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$77M
5
Temasek Holdings
Temasek Holdings
Singapore
+$69M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$322M
2
$146M
3
$139M
4
$77M
5
$69M
6
$65.5M
7
$14.5M
8
$10.2M
9
$8.86M
10
$8.48M
11
$7.82M
12
$7.66M
13
$4.89M
14
$3.91M
15
$3.13M
16
$3.12M
17
$2.83M
18
$2.19M
19
$1.85M
20
$1.56M
21
$1.48M
22
$1.48M
23
$1.33M
24
$743K
25
$709K
1
2